Skip to main content
. 2019 Oct 10;11(10):1526. doi: 10.3390/cancers11101526

Table 1.

Clinical and pathological characteristics of (A) NSCLC patients, (B) SCLC patients, and (C) healthy donors.

A
Variable NSCLC Patients (n = 95)
Histological subtype
Squamous 34 (35.8)
Non-squamous 61 (64.2)
Stage-n (%)
I 45 (47.4)
II 23 (24.2)
III 19 (20.0)
IV 8 (8.4)
Gender-n (%)
Female 26 (27.4)
Male 69 (72.6)
Age at diagnostic >75 y/o-n (%)
No 74 (77.9)
Yes 21 (22.1)
Smoking history-n (%)
Unknown 1 (1.1)
Never 4 (4.2)
Ex 57 (60.0)
Current 33 (34.7)
Pack per year
Median 40
Range 2–107
B
Variable SCLC Patients (n = 105)
Stage-n (%)
ED 69 (65.7)
LD 21 (20.0)
Unknown 15 (14.3)
Gender-n (%)
Female 38 (36.2)
Male 67 (63.8)
Age at diagnostic >75 y/o-n (%)
No 78 (74.3)
Yes 27 (25.7)
Smoking history-n (%)
Unknown 10 (9.5)
Never 1 (1.0)
Ex 32 (30.5)
Current 62 (59.0)
Pack per year
Median 43
Range 1–170
C
Variable Healthy Donors (n = 37)
Gender-n (%)
Female 3 (8.1)
Male 34 (91.9)
Age >75 y/o-n (%)
No 36 (97.3)
Yes 1 (2.7)
Agee (year)
Median 59.5
Range 19−79
Smoking history-n (%)
Unknown 19 (51.4)
Never 8 (21.6)
Yes 10 (27.0)

Abbreviations: ED, extensive-stage disease; LD, limited-stage disease; NSCLC, non-small-cell lung cancer; SCLC, small-cell lung cancer, y/o: Years old.